Soluble TREM2: Innocent bystander or active player in neurological diseases?

"We thank members of our laboratories for helpful discussions. The authors apologize for the omission of relevant work owing to space constraints. The work performed by our groups and cited in this review was supported by grants including: R01AG058501-01 (to L.P.) from the NIH/NIA; Fondazione Italiana Sclerosi Multipla (FISM; 2017/R/20) and co-financed with the ‘5 per mille’ public funding; Edward N. and Della L. Thome Memorial Foundation (to CMK), Chan Zuckerberg Initiative (to CMK), NIH AG062734 (to CMK). Authors have no conflicting financial interests."

"We thank members of our laboratories for helpful discussions. The authors apologize for the omission of relevant work owing to space constraints. The work performed by our groups and cited in this review was supported by grants including: R01AG058501-01 (to L.P.) from the NIH/NIA; Fondazione Italiana Sclerosi Multipla (FISM; 2017/R/20) and co-financed with the ‘5 per mille’ public funding; Edward N. and Della L. Thome Memorial Foundation (to CMK), Chan Zuckerberg Initiative (to CMK), NIH AG062734 (to CMK). Authors have no conflicting financial interests."